CXCR4 and breast carcinoma: In addition, tinzaparin suppressed the binding of malignant cells expressing the C-X-C chemokine receptor type 4- to their specific ligand on normal tissue, resulting in a substantial reduction of the dissemination of human breast cancer cells to the lung [43].